Alerts will be sent to your verified email
Verify EmailPANACEABIO
Panacea Biotec
|
Indoco Remedies
|
Zota Health Care
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
6.0 . | 57.0 . | n/a |
R&D as a % of Total Sales
|
5.51 % | 6.0 % | 0.09 % |
Financials
|
|||
5 yr Average ROE
|
17.16 % | 11.09 % | -1.91 % |
5yr average Equity Multiplier
|
1.61 | 1.79 | 1.71 |
5yr Average Asset Turnover Ratio
|
0.4 | 0.92 | 0.99 |
5yr Avg Net Profit Margin
|
19.26 % | 6.73 % | -0.52 % |
Price to Book
|
3.24 | 2.62 | 12.76 |
P/E
|
0.0 | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
-102.87 Days | 53.79 Days | 38.95 Days |
Inventory Days
|
109.97 Days | 66.59 Days | 94.16 Days |
Days Receivable
|
37.7 Days | 76.04 Days | 55.69 Days |
Days Payable
|
294.14 Days | 121.65 Days | 89.31 Days |
5yr Average Interest Coverage Ratio
|
2.9 | 7.97 | 18.17 |
5yr Avg ROCE
|
-1.68 % | 15.12 % | 1.25 % |
5yr Avg Operating Profit Margin
|
-1.99 % | 15.97 % | 5.05 % |
5 yr average Debt to Equity
|
0.05 | 0.38 | 0.03 |
5yr CAGR Net Profit
|
-64.03 % | 32.49 % | n/a |
5yr Average Return on Assets
|
6.95 % | 6.31 % | -0.16 % |
Shareholdings
|
|||
Promoter Holding
|
72.48 % | 58.9 % | 59.72 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.26 % |
Change in Promoter Holding (3 Yrs)
|
-1.11 % | 0.21 % | -8.39 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 1.0 % | 0.03 % |